Antibiotics have transformed modern medicine. They are essential for treating infectious
diseases and enable vital therapies and procedures. However, despite this success, their …

Acinetobacter baumannii (A. baumannii) is a leading cause of nosocomial infections as this
pathogen has certain attributes that facilitate the subversion of natural defenses of the …

Carbapenem-resistant Acinetobacter baumannii (CRAB) causes colonization and infection
predominantly in hospitalized patients. Distinction between the two is a challenge. When …

Acinetobacter baumannii is an opportunistic bacterial pathogen primarily associated with
hospital-acquired infections. The recent increase in incidence, largely associated with …

Acinetobacter baumannii has emerged as a medically important pathogen because of the
increasing number of infections produced by this organism over the preceding three …

Acinetobacter baumannii is one of the major pathogenic ESKAPE bacterium, which is
responsible for about more than 722,000 cases in a year, globally. Despite the alarming …

The genus Acinetobacter comprises a complex and heterogeneous group of bacteria, many
of which are capable of causing a range of opportunistic, often catheter‐related, infections in …

As the threat of antimicrobial-resistant bacteria compromises the safety and efficacy of
modern healthcare practices, the search for effective treatments is more urgent than ever …

Acinetobacter baumannii is a nosocomial opportunistic pathogen that can cause severe
infections, including hospital-acquired pneumonia, wound infections, and sepsis. Multidrug …

The objective of the present report was to review briefly the potentially community-acquired
Acinetobacter baumannii infections, to update information on the reservoirs of A. baumannii …